Unity Biotechnology, Inc. Long-Term Debt, Maturity, Year Two
Unity Biotechnology, Inc. had Long-Term Debt, Maturity, Year Two of $9.92 million as of 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2023-03-15
- 2022-12-31: Long-Term Debt, Maturity, Year Two $9.92M.
- 2022-09-30: Long-Term Debt, Maturity, Year Two $9.36M.
- 2022-06-30: Long-Term Debt, Maturity, Year Two $7.18M.
- 2022-03-31: Long-Term Debt, Maturity, Year Two $7.12M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2022-12-31 | $9.92M 10-K · filed 2023-03-15 |
| 2022-09-30 | $9.36M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.18M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $7.12M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $11.14M 10-K · filed 2022-03-15 |
| 2021-09-30 | $12.27M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $12.27M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $12.27M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $3.84M 10-K · filed 2021-03-23 |
| 2020-09-30 | $3.84M 10-Q · filed 2020-11-04 |